EPA:MKEA - Euronext Paris - Matif - FR0010609263 - Common Stock - Currency: EUR
EPA:MKEA (8/7/2023, 7:00:00 PM)
0.62
0 (0%)
The current stock price of MKEA.PA is 0.62 EUR. In the past month the price decreased by -3.43%. In the past year, price decreased by -29.47%.
Symbol | Company Name | TA | FA | PE | Market Cap |
---|---|---|---|---|---|
ABL.DE | ABBOTT LABORATORIES | 28.22 | 207.98B | ||
IUI1.DE | INTUITIVE SURGICAL INC | 73.65 | 179.25B | ||
1ISRG.MI | INTUITIVE SURGICAL INC | 73.56 | 178.94B | ||
BSX.DE | BOSTON SCIENTIFIC CORP | 38.58 | 136.96B | ||
2M6.DE | MEDTRONIC PLC | 16.42 | 100.04B | ||
SHL.DE | SIEMENS HEALTHINEERS AG | 21.68 | 55.04B | ||
BOX.DE | BECTON DICKINSON AND CO | 12.46 | 44.79B | ||
1BDX.MI | BECTON DICKINSON AND CO | 11.65 | 41.87B | ||
EWL.DE | EDWARDS LIFESCIENCES CORP | 28.98 | 39.36B | ||
DC4.DE | DEXCOM INC | 52.28 | 30.13B | ||
PHIA.AS | KONINKLIJKE PHILIPS NV | 16.15 | 20.65B | ||
PHI1.DE | KONINKLIJKE PHILIPS NV | 16.1 | 20.58B |
Mauna Kea Technologies SA engages in the design, development, and sale of optical biopsy devices and tools to visualize and detect abnormalities in the gastro-intestinal and pulmonary tracts primarily in cancer patients. The company is headquartered in Paris, Ile-De-France and currently employs 56 full-time employees. The company went IPO on 2011-07-05. The firm focuses on eliminating uncertainties related to the diagnosis and treatment of cancer and other diseases thanks to real time in vivo microscopic visualization. The Company’s flagship product is Cellvizio, a confocal laser endomicroscopy platform using microprobes and needles. This technological platform enables to view tissues at cellular level, in real time, during standard procedure. Cellvizio can be used in gastroenterology, pulmonology, or urology. The firm markets its technological platform in more than 40 countries, including the United States, Europe, Japan, China, South Korea as well as several Latin American countries.
MAUNA KEA TECHNOLOGIES
9, rue d'Enghien
Paris ILE-DE-FRANCE FR
Employees: 56
Phone: 33148240345.0
The current stock price of MKEA.PA is 0.62 EUR.
The exchange symbol of MAUNA KEA TECHNOLOGIES is MKEA and it is listed on the Euronext Paris - Matif exchange.
MKEA.PA stock is listed on the Euronext Paris - Matif exchange.
8 analysts have analysed MKEA.PA and the average price target is 1.99 EUR. This implies a price increase of 220.81% is expected in the next year compared to the current price of 0.62. Check the MAUNA KEA TECHNOLOGIES stock analysts ratings, price target forecast and up-and down grades for more detailed information.
MAUNA KEA TECHNOLOGIES (MKEA.PA) has a market capitalization of 28.74M EUR. This makes MKEA.PA a Nano Cap stock.
MAUNA KEA TECHNOLOGIES (MKEA.PA) currently has 56 employees.
MAUNA KEA TECHNOLOGIES (MKEA.PA) has a support level at 0.61 and a resistance level at 0.62. Check the full technical report for a detailed analysis of MKEA.PA support and resistance levels.
The Revenue of MAUNA KEA TECHNOLOGIES (MKEA.PA) is expected to decline by -18.48% in the next year. Check the estimates tab for more information on the MKEA.PA EPS, Sales, EBIT and EBITDA future analyst estimates.
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
MKEA.PA does not pay a dividend.
MAUNA KEA TECHNOLOGIES (MKEA.PA) does not have a PE ratio as the earnings reported over the last twelve months were negative (-0.25).
ChartMill assigns a technical rating of 1 / 10 to MKEA.PA. When comparing the yearly performance of all stocks, MKEA.PA is a bad performer in the overall market: 84.84% of all stocks are doing better.
ChartMill assigns a fundamental rating of 1 / 10 to MKEA.PA. MKEA.PA may be in some trouble as it scores bad on both profitability and health.
Over the last trailing twelve months MKEA.PA reported a non-GAAP Earnings per Share(EPS) of -0.25. The EPS increased by 28.86% compared to the year before.
Industry Rank | Sector Rank | ||
---|---|---|---|
PM (TTM) | N/A | ||
ROA | N/A | ||
ROE | N/A | ||
Debt/Equity | N/A |
ChartMill assigns a Buy % Consensus number of 88% to MKEA.PA. The Buy consensus is the average rating of analysts ratings from 8 analysts.
For the next year, analysts expect an EPS growth of -62.13% and a revenue growth -18.48% for MKEA.PA